A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care

Abstract

There has been considerable debate concerning the cost-effectiveness of selective serotonin re-uptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs) thus far using crude prescription price comparisons or reductionist decision-analytic model